S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Critical asset just had biggest fall on record (Ad)
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
From Hometown Hero to Franchise Partner — 3 Celebrities Collaborating With Their Hometown Brands

Spectral AI (MDAI) Competitors

$2.00
-0.06 (-2.91%)
(As of 02/29/2024 ET)

MDAI vs. NMTC, CODX, FEMY, NEPH, DXR, MODD, AKLI, RVP, ICU, and CTSO

Should you be buying Spectral AI stock or one of its competitors? The main competitors of Spectral AI include NeuroOne Medical Technologies (NMTC), Co-Diagnostics (CODX), Femasys (FEMY), Nephros (NEPH), Daxor (DXR), Modular Medical (MODD), Akili (AKLI), Retractable Technologies (RVP), SeaStar Medical (ICU), and Cytosorbents (CTSO). These companies are all part of the "surgical & medical instruments" industry.

Spectral AI vs.

Spectral AI (NASDAQ:MDAI) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings.

NeuroOne Medical Technologies received 62 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 71.59% of users gave NeuroOne Medical Technologies an outperform vote.

CompanyUnderperformOutperform
Spectral AIOutperform Votes
1
100.00%
Underperform Votes
No Votes
NeuroOne Medical TechnologiesOutperform Votes
63
71.59%
Underperform Votes
25
28.41%

Spectral AI has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -478.41%. Spectral AI's return on equity of -1.62% beat NeuroOne Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AIN/A -1.62% -48.97%
NeuroOne Medical Technologies -478.41%-267.82%-200.46%

Spectral AI presently has a consensus price target of $4.00, suggesting a potential upside of 100.00%. NeuroOne Medical Technologies has a consensus price target of $2.20, suggesting a potential upside of 81.82%. Given Spectral AI's higher possible upside, equities research analysts plainly believe Spectral AI is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
NeuroOne Medical Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

3.2% of Spectral AI shares are owned by institutional investors. Comparatively, 18.9% of NeuroOne Medical Technologies shares are owned by institutional investors. 0.4% of Spectral AI shares are owned by company insiders. Comparatively, 7.5% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Spectral AI had 4 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 7 mentions for Spectral AI and 3 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.87 beat Spectral AI's score of 0.72 indicating that NeuroOne Medical Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NeuroOne Medical Technologies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Spectral AI has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500.

Spectral AI has higher earnings, but lower revenue than NeuroOne Medical Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AIN/AN/A$11.04MN/AN/A
NeuroOne Medical Technologies$1.95M16.09-$11.86M-$0.68-1.78

Summary

Spectral AI beats NeuroOne Medical Technologies on 7 of the 13 factors compared between the two stocks.


Get Spectral AI News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MDAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDAI vs. The Competition

MetricSpectral AISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$33.49M$3.79B$4.90B$7.51B
Dividend YieldN/A2.06%2.87%3.87%
P/E RatioN/A16.24240.0016.68
Price / SalesN/A38.163,150.78301.28
Price / Cash1.1825.1195.4255.16
Price / Book-1.053.774.454.54
Net Income$11.04M$19.87M$114.12M$211.48M
7 Day Performance6.95%2.06%4.23%2.63%
1 Month Performance-8.68%2.13%8.74%5.46%
1 Year PerformanceN/A1.22%12.11%8.67%

Spectral AI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NMTC
NeuroOne Medical Technologies
2.2454 of 5 stars
$1.15
-0.9%
$2.20
+91.3%
-24.8%$29.82M$2.82M-1.6916
CODX
Co-Diagnostics
3.4981 of 5 stars
$1.13
+0.9%
$3.00
+165.5%
-60.9%$34.56M$4.66M-0.81145Short Interest ↑
News Coverage
FEMY
Femasys
3.2297 of 5 stars
$1.62
+14.1%
$9.00
+455.6%
+60.0%$35.07M$1.21M-1.6734Short Interest ↓
Gap Up
NEPH
Nephros
1.628 of 5 stars
$3.35
-2.9%
N/A+189.9%$35.11M$9.98M0.0027Short Interest ↓
News Coverage
DXR
Daxor
0 of 5 stars
$7.62
-1.9%
N/AN/A$36.12MN/A0.00N/AShort Interest ↑
Gap Down
MODD
Modular Medical
3.218 of 5 stars
$1.66
-3.5%
$4.25
+156.0%
-10.0%$36.35MN/A-1.7137
AKLI
Akili
3.639 of 5 stars
$0.47
+2.2%
$4.00
+760.2%
-76.8%$36.41M$320,000.00-0.4266Short Interest ↓
Gap Down
RVP
Retractable Technologies
0 of 5 stars
$1.29
flat
N/A-33.0%$38.62M$94.82M-3.49190Analyst Report
News Coverage
Gap Down
ICU
SeaStar Medical
2.778 of 5 stars
$0.77
-8.3%
$5.00
+547.8%
-75.3%$42.55MN/A0.009Short Interest ↑
CTSO
Cytosorbents
2.0917 of 5 stars
$0.96
-2.0%
$2.50
+160.4%
-68.9%$42.66M$34.69M-1.81198Gap Down

Related Companies and Tools

This page (NASDAQ:MDAI) was last updated on 3/1/2024 by MarketBeat.com Staff